Psychiatric medication protects developing mouse brain from birth defects

June 19, 2017, Society for Neuroscience
Photograph shows decreased brain size in an infected, untreated mouse (mCMV, middle), compared to an uninfected control (left). Credit: Anthony van den Pol et al., The Journal of Neuroscience

A clinically available anxiety drug safely and effectively protects against brain defects caused by the mouse version of a common human virus, finds new research published in The Journal of Neuroscience.

More than half of U.S. adults are infected with cytomegalovirus (CMV), but most people do not experience any symptoms because a healthy immune system keeps the in check. However, CMV infection in babies can cause unusually small brain size (microcephaly) like the less common Zika virus, deafness, blindness, mental dysfunction, and other neurological problems that can last a lifetime. There is no effective CMV vaccine, and current treatments are not recommended during pregnancy or in newborns because of their potential to cause other birth defects and cancer.

Anthony van den Pol and colleagues found that a daily low dose of the mood stabilizer valnoctamide reduced the amount of CMV in the body of infected newborn mice and suppressed further replication of the virus that had already reached the brain, without negative side effects. The treatment also normalized neurological and behavioral development in the infected mice, including impaired social interactions thought to link CMV infection and . Finally, the authors show that the drug suppresses replication of CMV in human fetal brain cells.

Explore further: Immune molecule protects against Zika virus infection in animal models

More information: Valnoctamide inhibits cytomegalovirus infection in developing brain and attenuates neurobehavioral dysfunctions and brain abnormalities, Journal of Neuroscience (2017). content/early/2017/06/19/JNEUROSCI.0970-17.2017

Related Stories

Immune molecule protects against Zika virus infection in animal models

March 14, 2017
A molecule naturally produced by the immune system protects mice and monkeys against Zika virus infection, an international team of researchers has found. Administering the molecule, called 25-hydroxycholesterol or 25HC, ...

Maternal-fetal transmission of Zika virus and therapeutic approaches to prevent it

June 5, 2017
The devastating effects of Zika virus on the brain of the developing fetus during infection in pregnancy have led to intensive research to understand the routes of Zika virus transmission and how the virus travels to and ...

Two mood drugs combat virus implicated in birth defects

September 21, 2016
Two mood-stabilizing drugs provide protection against a potentially dangerous virus implicated in birth defects as well as disease in people with compromised immune systems, Yale School of Medicine researchers have found.

Scientists develop new mouse model to aid Zika virus research

November 17, 2016
Researchers have developed a new mouse model that could be used in Zika research to better understand the virus and find new treatments, according to a study published in PLOS Pathogens.

New insights into how the Zika virus causes microcephaly

June 1, 2017
A study published today in Science shows that the Zika virus hijacks a human protein called Musashi-1 (MSI1) to allow it to replicate in, and kill, neural stem cells. Almost all MSI1 protein in the developing embryo is produced ...

Mouse model reveals extensive postnatal brain damage caused by Zika infection

November 22, 2016
A team of scientists led by researchers at the University of Georgia has developed a new mouse model that closely mimics fetal brain abnormalities caused by the Zika virus in humans.

Recommended for you

New neuron-like cells allow investigation into synthesis of vital cellular components

January 22, 2018
Neuron-like cells created from a readily available cell line have allowed researchers to investigate how the human brain makes a metabolic building block essential for the survival of all living organisms. A team led by researchers ...

Finding unravels nature of cognitive inflexibility in fragile X syndrome

January 22, 2018
Mice with the genetic defect that causes fragile X syndrome (FXS) learn and remember normally, but show an inability to learn new information that contradicts what they initially learned, shows a new study by a team of neuroscientists. ...

Epilepsy linked to brain volume and thickness differences

January 22, 2018
Epilepsy is associated with thickness and volume differences in the grey matter of several brain regions, according to new research led by UCL and the Keck School of Medicine of USC.

Research reveals atomic-level changes in ALS-linked protein

January 18, 2018
For the first time, researchers have described atom-by-atom changes in a family of proteins linked to amyotrophic lateral sclerosis (ALS), a group of brain disorders known as frontotemporal dementia and degenerative diseases ...

Fragile X finding shows normal neurons that interact poorly

January 18, 2018
Neurons in mice afflicted with the genetic defect that causes Fragile X syndrome (FXS) appear similar to those in healthy mice, but these neurons fail to interact normally, resulting in the long-known cognitive impairments, ...

How your brain remembers what you had for dinner last night

January 17, 2018
Confirming earlier computational models, researchers at University of California San Diego and UC San Diego School of Medicine, with colleagues in Arizona and Louisiana, report that episodic memories are encoded in the hippocampus ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.